From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice
Pharmacology Research & Perspectives · 2026-06 · 14 (3)
DOI: 10.1002/prp2.70262 ↗At a glance
Journal article in Pharmacology Research & Perspectives, published online on 2026-05-10. Written by Jessie Kim and 2 co-authors. Institution: Department of Psychiatry, University of California San Diego, San Diego, California, USA. Cited 1 times so far (Crossref); 18 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Intet abstract tilgængeligt.
Authors and institutions
- Department of Psychiatry, University of California San Diego, San Diego, California, USA.
- University of Queensland School of Medicine, Herston, Queensland, Australia.
Cite
APA
Kim, J., Lochhead, L., & Weissman, C. R. (2026). From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice. Pharmacology Research & Perspectives, 14(3). https://doi.org/10.1002/prp2.70262
Vancouver
Kim J, Lochhead L, Weissman CR. From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice. Pharmacology Research & Perspectives. 2026;14(3). doi:10.1002/prp2.70262
BibTeX
@article{Kim2026,
author = {Kim, Jessie and Lochhead, Liam and Weissman, Cory R},
title = {From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/prp2.70262}
}
EUVIMED